سعر ماسكجلوكوم قطرة عين 10مل 5% 2022

Mascglucom eye drops 10 ml, levobunolol ophthalmic solution (stated strength 5%) by Sigma Tec > Concord Pharmaceutical Industries; listed in Egyptian price directories under antiglaucoma.

• Transient ocular burning and stinging (up to 1 in 3 patients) and blepharoconjunctivitis (up to 1 in 20); decreases in heart rate and blood pressure have been reported.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Bronchial asthma or a history of it, severe chronic obstructive pulmonary disease, sinus bradycardia, second- or third-degree AV block, overt cardiac failure, cardiogenic shock, or hypersensitivity to any component.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• May be absorbed systemically; severe respiratory and cardiac reactions, including death from bronchospasm in asthmatics and rarely death with cardiac failure, have been reported with topical beta-blockers.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Use with caution in diabetes (may mask hypoglycaemia), thyrotoxicosis (may mask signs; avoid abrupt withdrawal), vascular insufficiency, cerebrovascular insufficiency, myasthenia-like weakness and before major surgery.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• The US product contains sodium metabisulfite, which may cause allergic-type reactions in sulfite-sensitive people.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Oral beta-blockers / other topical beta-blockersPotential additive effects on systemic beta-blockade or intraocular pressure; two topical ophthalmic beta-blockers should not typically be used together.DailyMed (U.S. National Library of Medicine)
• Calcium channel blockers (oral or IV) / digitalisMonitor for AV conduction disturbances, left ventricular failure and hypotension; avoid simultaneous use in impaired cardiac function.DailyMed (U.S. National Library of Medicine)
• Catecholamine-depleting drugs (e.g. reserpine)Possible additive hypotension and/or marked bradycardia.DailyMed (U.S. National Library of Medicine)

• No adequate and well-controlled studies in pregnant women; fetotoxicity was seen in rabbits at 200-700 times the human glaucoma dose. Use in pregnancy only if the potential benefit justifies the potential risk to the fetus.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk (systemic beta-blockers and topical timolol are); use with caution in nursing women.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Careful monitoring of patients is advised when starting therapy (intraocular pressure response; heart rate and blood pressure, as systemic beta-blockade can occur).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Levobunolol: Non-selective beta-1/beta-2 blocker; lowers intraocular pressure mainly by decreasing aqueous humour production (US label).